An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Through the Kenya Medical Supplies Authority (KEMSA) Chief Executive Officer Waqo Erjesa, the government confirmed that there ...

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

Kenya has completely run out of essential medical supplies—including HIV medicines, testing kits, and vaccines—putting ...

Counties are facing limited supplies or no stock at all, leaving newborns vulnerable to TB. Health advocates are urging the ...

The country’s public and private hospitals are facing severe shortages of Atazanavir, a crucial HIV drug, as well as condoms, ...

Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.